HARROW, INC. — Director's Dealing 2017

Apr 18, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-04-13

Reporting Person: Edwards Clayton D (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$4.13	2016-09-01	Common Stock (55000)		Direct

Footnotes

F1: The stock option was granted on September 1, 2016 pursuant to the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests over a 4-year period, with 25% of the total number of shares subject to the option vesting on the one-year anniversary of the grant date and the remaining shares subject to the option vesting in equal installments each quarterly period following the one-year anniversary of the grant date.